Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
33,057
Sort by:
Global Chronic Disease Management Therapeutics and Device Technologies Market Size study & Forecast, by Disease (Cardiovascular diseases (CVD), Diabetes, Cancer, Chronic respiratory diseases, Chronic kidney diseases, Neurological disorders, Others (such as autoimmune diseases, gastrointestinal disorders, and many)) by Therapy (Medications, Rehabilitation therapy, Behavioral therapy, Others (such as gene therapy, stem cell therapy, and many)), by Device (Blood glucose monitoring devices, Blood pressure monitors, Cardiac monitors, Respiratory therapy devices, Kidney dialysis machines, Neurostimulation devices, Others (such as insulin pumps, continuous glucose monitoring devices, and many)) and Regional Analysis, 2023-2030
US$ 4,950.00
Global Chronic Disease Management Therapeutics and Device Technologies Market is valued at approximately USD 20.35 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 1....
May 2023
200 pages
Global Generic Pharmaceuticals Market Size study & Forecast, by Type ( Simple Generics, Specialty Generics, Biosimilars), by Application ( Central Nervous System Disorders, Respiratory Diseases, Hormones & Related Diseases, Gastrointestinal Diseases, Cardiovascular Diseases, Infectious Diseases and Others), by Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable and Others), by Distribution Channel (Online Pharmacies, Hospitals Pharmacies, Retail Pharmacies)and Regional Analysis, 2023-2030
US$ 4,950.00
Global Generic Pharmaceuticals Market is valued at approximately USD 361.7 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.3% over the forecast period 2022-2029. G...
May 2023
200 pages
Global Soft Tissue Sarcoma Market Size study & Forecast, by Treatment (Targeted Therapy, Chemotherapy, Anti-Angiogenesis Drugs, Radiation Therapy), By Route of Administration (Oral, Parenteral, Others), By End-users (Hospitals, Homecare, Speciality Centres, Others), and Regional Analysis, 2023-2030
US$ 4,950.00
Global Soft Tissue Sarcoma Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Soft tiss...
May 2023
200 pages
Prebiotics Market by Ingredient (Inulin, Fructo-oligosaccharides, Galacto-oligosaccharides, Mannan-oligosaccharides), Application (Food & Beverages {Dairy Products, Beverages, Infant Food Products}, Dietary Supplements), and Geography—Forecast to 2029
US$ 4,175.00
Prebiotics Market by Ingredient (Inulin, Fructo-oligosaccharides, Galacto-oligosaccharides, Mannan-oligosaccharides), Application (Food & Beverages {Dairy Products, Beverages, Infant Food Products}, D...
May 2023
172 pages
Global Osteoarthritis Therapeutics Market Size study & Forecast, by Anatomy (Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Small Joint Osteoarthritis) by Drug Type (Viscosupplementation Agents, Non-steroidal Anti-inflammatory Drugs, Analgesics,Corticosteroids), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Analysis, 2022-2029
US$ 4,950.00
Global Osteoarthritis Therapeutics Market is valued approximately USD 7348.46 million in 2021 and is anticipated to grow with a healthy growth rate of more than 8.8% over the forecast period 2022-2029...
May 2023
200 pages
Global Psychedelic Drugs Market Size study & Forecast, by Drug Type (Gamma Hydroxybutyric Acid (GHB), Ketamine, Psilocybin, Lysergic Acid Diethylamide (LSD), 3 4-MethylEnedioxyMethamphetamine, Other Drug Types) by Application (Treatment Resistant Depression, Opiate Addiction, Post-traumatic Stress Disorder, Narcolepsy, Panic Disorders, Other Applications), By Distribution Channel ( Hospital pharmacy, Retail pharmacy and Other Distribution Channels) and Regional Analysis, 2022-2029
US$ 4,950.00
Global Psychedelic Drugs Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Psychedelic dr...
May 2023
200 pages
CIN & HR-HPV Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Disease Type (Cervical Intraepithelial Neoplasia 1, Cervical Intraepithelial Neoplasia 2, and Cervical Intraepithelial Neoplasia 3), Strain Type (HPV 16, HPV 18, and Others), Offering (Diagnostic Method and Treatment), Product Type (Kits & Reagents, Instruments, and Services), and End User (Hospitals & Clinics, Diagnostic Laboratories, Specialized Clinical Laboratories, and Others)
US$ 4,550.00
The CIN & HR-HPV treatment market size was US$ 11,635.17 million in 2022, and it is projected to reach US$ 17,164.61 million by 2028; the market is estimated to record a CAGR of 6.7% from 2023 to 2028...
May 2023
245 pages
Global Bioengineered protein drugs Market Size study & Forecast, by Drug Type( Recombinant Protein Drugs, Peptide Hormones, Vaccines, Therapeutic Enzymes, Monoclonal Antibodies, Cytokines and Others) by Disease ( Diabetes, Cancer, Skin Diseases , Blood disorders, Heart Diseases, Neurodegenerative Diseases and Others), by Technology (Fractionation, Bioreactors And Microbial Cell Fermentation, Genetic Engineering, Genetically Modified Organisms, Pharming and Others), by Drug Delivery Method (Traditional Methods, Novel approaches according to recent research) and Regional Analysis, 2022-2029
US$ 4,950.00
Global Bioengineered protein drugs Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Bioe...
May 2023
200 pages
Global Dystonia Drugs Market Size study & Forecast, by Drug Type (Anticonvulsants drugs, Dopaminergic agents, GABAergic agents, Others) by Route of Administration (Oral, Injectable), by Distribution Channel (Hospital Pharmacies, Online Providers, Drug Stores and Retail Pharmacies) and Regional Analysis, 2022-2029
US$ 4,950.00
Global Dystonia Drugs Market is valued at approximately USD 806.7 million in 2021 and is anticipated to grow with a healthy growth rate of more than 5.5% over the forecast period 2022-2029. Dystonia m...
May 2023
200 pages
Global Liver Disease Treatment Market Size study & Forecast, by Treatment Type (Antiviral Drugs, Immunosuppressants, Vaccines, Immunoglobulins, Corticosteroids, Targeted Therapy, Chemotherapy), by Disease Type (Hepatitis, Autoimmune Diseases, Non-alcoholic Fatty Liver Disease (NAFLD), Cancer, Genetic Disorders, Others) and Regional Analysis, 2022-2029
US$ 4,950.00
Global Liver Disease Treatment Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. The...
May 2023
200 pages
Global Opioid Use Disorder (OUD) Market Size study & Forecast, by Drug Class (Buprenorphine, Methadone, Naltrexone), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Stores, Online Pharmacies) and Regional Analysis, 2022-2029
US$ 4,950.00
Global Opioid Use Disorder (OUD) Market is valued at approximately USD 2.88 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.9% over the forecast period 2022-2029....
May 2023
200 pages
Global Skeletal Dysplasia Market Size Study & Forecast, by Type (X-linked hypophosphatemia, Hypophosphatasia, Achondroplasia, Fibrodysplasia ossificans progressive, Multiple osteochondromas, Others), by Treatment (Medication, Surgery, Others) and Regional Analysis, 2022-2029
US$ 4,950.00
Global Skeletal Dysplasia Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Skeletal d...
May 2023
200 pages
Europe Radioactive Tracers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Test Type (PET, SPECT, and Others), End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others), Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], and Application (Oncology, Pulmonary, Neurology, Cardiology, and Others)
US$ 3,000.00
The Europe radioactive tracers market size is expected to grow from US$ 4,175.25 million in 2022 to US$ 11,005.25 million by 2028; it is estimated to register a CAGR of 17.5% from 2023 to 2028. The ri...
May 2023
232 pages
Neurotoxin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Botox, Dysport, Xeomin, and Others), Application (Therapeutic and Aesthetic), and End User (Hospitals, Specialty Clinics, Dermatology Clinics, and Others)
US$ 4,550.00
The neurotoxin market size is expected to reach US$ 13,195.06 million by 2028 from US$ 6,622.36 million in 2022; it is estimated to record a CAGR of 12.3% from 2023 to 2028. The overall market for neu...
May 2023
186 pages
Nuclear Medicine Market / Radiopharmaceuticals Market by Type (Diagnostic (SPECT-Technetium, PET-F-18), Therapeutic (Beta Emitters-Y-90, Alpha Emitters, Brachytherapy), Application (Neurology,Thyroid, Oncology), Procedures, End User - Global Forecast to 2028
US$ 4,950.00
... the PET nuclear medicine market during the forecast period” Based on type, the nuclear medicine market is segmented into diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals. The diagnostic radiopharmaceuticals have been segmented ...
May 2023
342 pages
Bispecific Antibodies Market (5th Edition): Distribution by Therapeutic Area (Autoimmune Disorders, Genetic Disorders, Hematological Malignancies, Ophthalmic Disorders, Skin Cancers And Solid Tumors), Mechanism of Action (Cytokines Retargeting / Neutralization, Dual Ligands Blocking, Resistance Factors Co-Targeting, Targeting Tumor Angiogenesis, T-Cell Retargeting / Activation and Others), Target Antigen (C5-Albumin, CD20 x CD3, CD3 x BCMA, CD3 x CD19, EGFR x cMET, EpCAM x CD3, Factor IXa x Factor X, gp100 x CD3, HER2 x HER2, PD-1 x CTLA-4, PD-L1 x TGF?, TNF-? x HAS, VEGF x DLL4 and VEGF-A x ANG2), Antibody Format (Asymmetric And Fragments), Key Players (Akeso Biopharma, Alexion, Amgen, Genmab, Immunocore, Janssen Research & Development, Linton Pharm, Merck, OncXerna Therapeutics, Pfizer, Roche, Taisho Pharmaceutical and Zymeworks) and Key Geographical Regions (North America, Europe, Asia and Rest of the World): Industry Trends and Global Forecasts, 2023-2035
US$ 4,799.00
The bispecific antibodies market is expected to reach USD 5.6 billion by 2023 and is anticipated to grow at a CAGR of 9.5% during the forecast period 2023-2035 Bispecific antibodies (BsAbs) represent...
May 2023
391 pages
Pharmaceutical Packaging Market Research (China)
US$ 4,000.00
China's demand for Pharmaceutical Packaging has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...
April 2023
224 pages
North America In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Technique (Double-Syringe Mixing Configuration, Laser Teeth Whitening, Deep Bleaching, Brite Smile Whitening System, and Others), Solution [Teeth Whitening Kits/Refill Kits, Teeth Whitening LED Lights, Teeth Whitening Pen/ Syringe Gel, Teeth Whitening Powder and Toothpaste, Teeth Whitening Strips, Custom Tray-Based Tooth Whitening Systems, and Others (Toothbrush/ Whitening Mouthwash etc)], Composition (Carbamide Peroxide, Hydrogen Peroxide, and Others), and End User [Hospitals, Dental Clinics/Offices, and Others], Distribution Channel [Manufacturers, Distributors/Suppliers, Others(Third-Part Suppliers)] and Country
US$ 3,000.00
The North America in-office teeth whitening products market size is expected to reach US$ 5,818.23 million by 2028 from US$ 3,748.76 million in 2022. The market is estimated to record a CAGR of 7.6% f...
April 2023
157 pages
Pharmaceutical Contract Manufacturing Market by Service (Pharmaceutical (API, FDF - Tablet, Capsule, Injectable)), Biologic (API, FDF), Drug Development), End User (Big Pharma, Small & Medium-sized Pharma, Generic Pharma) - Global Forecast to 2028
US$ 4,950.00
... pharmaceutical contract development and manufacturing market is segmented into pharmaceutical manufacturing, biologics manufacturing, and drug development services. The biologics manufacturing segment is projected to witness the highest growth in the pharmaceutical contract development and manufacturing ...
April 2023
279 pages
US Intravenous Immunoglobulin Market Forecast to 2028 - COVID-19 Impact and Country Analysis By Type (IgG, IgM, IgA, and Others), Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Idiopathic Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-Barre Syndrome, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others), and End User (Hospitals, Specialty Clinics, and Others)
US$ 3,000.00
The US intravenous immunoglobulin market size was valued at US$ 4,439.26 million in 2022 and is projected to reach US$ 7,105.63 million by 2028; it is estimated to grow at a CAGR 8.2% during 2023–2028...
April 2023
145 pages
Psychedelic Drugs: Global Market Outlook
US$ 3,500.00
Report : This report includes sales forecasts and trends in the market for psychedelic drugs through 2027. It discusses leading companies in the market, product segments, supporting technologies, mark...
April 2023
35 pages
Global Antibiotics Market - Distribution by Type of Drug Class (Aminoglycosides, Cephalosporins, Fluoroquinolones, Macrolides, Oxazolidinones, Penicillins, Sulphonamides, Tetracyclines and Other Drug Classes), Target Disease Indication (Bacterial Infections, Skin Infections, Gastrointestinal Infections, Hematological Infections, Nephrological Infections, Pulmonary Infections, Reproductive Tract Infections, Respiratory Tract Infections, Sexually Transmitted Diseases, Urinary Tract Infections and Other Bacterial Infections), Type of Therapy (Monotherapies and Combination Therapies), Route of Administration (Intravenous and Oral), Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World), and Drug-wise Sales: Industry Trends and Global Forecasts, 2023-2035
US$ 4,799.00
The global antibiotics market is expected to reach USD 36 billion in 2023 anticipated to grow at a CAGR of 1.2% during the forecast period 2023-2035. Bacterial infections stand as a primary contributo...
April 2023
175 pages
Oral Solid Dosage Contract Manufacturing Market: Distribution by Type of Finished Dosage Form (Tablets, Capsules, Powders, Multi-particulates and Others), Type of Packaging (Bottles, Blisters, Sachets, Inhalers and Others), Scale of Operation (Pre-commercial and Commercial), Company Size (Small, Mid-sized, Large and Very Large), Therapeutic Area (Oncological Disorders, Infectious Diseases, Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Genetic Disorders, Respiratory Disorders, Immunological Disorders, and Other Disorders), and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa): Industry Trends and Global Forecasts
US$ 4,799.00
The global oral solid dosage contract manufacturing market is expected to reach USD 21 billion in 2023 anticipated to grow at a CAGR of 5% during the forecast period 2023-2035. Over time, the growing...
March 2023
296 pages
Radiopharmaceutical Theranostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type [Alpha Emitters, Beta Emitters, and Positron Emission Tomography (PET) Tracers], Radioisotope [Technetium-99, Gallium-68, Iodine-131, Iodine-123, 18F, Y-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (DX)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes, and Others)
US$ 4,550.00
The radiopharmaceutical theranostics market is expected to reach US$ 3,441.97 million by 2028 from US$ 1,814.58 million in 2022; it is estimated to grow at a CAGR of 11.3% from 2022 to 2028. The risin...
March 2023
185 pages
Drug Discovery Services Market by Process (Target Selection, Hit-to-lead), Type (Chemistry, Biology), Drug Type (Small Molecule, Biologics), Therapeutic Area (Oncology, Neurology, Infectious), End User (Pharma, Biotech, Academic) & Region - Global Forecasts to 2028
US$ 4,950.00
... analyzes the market for various drug discovery services across geographies Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the drug discovery services market
March 2023
334 pages
Global Markets for Bioengineered Protein Drugs
US$ 5,500.00
The global market for bioengineered protein drugs is expected to reach $228.4 billion by 2021 from $172.5 billion in 2016, rising at a compound annual growth rate (CAGR) of 5.8% from 2016 through 2021 ...
March 2023
185 pages
North America Radiopharmaceutical Theranostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type [Alpha Emitters, Beta Emitters, and Positron Emission Tomography (PET) Tracers], Radioisotope [Technetium-99, Gallium-68, Iodine-131, Iodine-123, Yttrium-90 (Y-90), Fluorine-18 (18F), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (CDx)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes, and Others)
US$ 3,000.00
The North America radiopharmaceutical theranostics market is expected to reach US$ 1,529.88 million by 2028 from US$ 795.88 million in 2022; it is estimated to grow at a CAGR of 11.5% from 2022 to 202...
March 2023
185 pages
Global Big Pharma Partnering Terms and Agreements 2016-2023
US$ 3,995.00
... an agreement contract published at the SEC a link provides online access to the contract. Chapter 4 provides a comprehensive listing of the top 25 most active companies including Pfizer, Sanofi, Abbott, GlaxoSmithKline, Johnson & Johnson ...
March 2023
2000 pages
Global Pharmaceutical Partnering Terms and Agreements 2018-2023
US$ 3,995.00
SUMMARY Global Pharmaceutical Partnering Terms and Agreements 2014 to 2019 report provides a detailed understanding and analysis of how and why companies enter Pharmaceutical partnering deals DESCRIPTION Global Pharmaceutical Partnering Terms and Agreements 2014 ...
March 2023
4000 pages
Global Specialty Pharmaceutical Partnering Terms and Agreements 2016-2023
US$ 3,995.00
SUMMARY Global Specialty Pharmaceutical Partnering Terms and Agreements 2014 to 2019 report provides a detailed understanding and analysis of how and why companies enter Specialty Pharmaceutical partnering deals DESCRIPTION Global Specialty Pharmaceutical Partnering Terms and Agreements 2014 ...
March 2023
750 pages
Esterified Vitamins Market Size, Share, and Analysis, By Distribution Channel (Online Retail, Supermarkets, Others (e.g. Specialty Stores, etc.)), By End Use (Pharmaceutical, Nutraceutical, Others) and Regional Forecasts, 2022-2032
US$ 4,950.00
Esterified Vitamins Market Size, Share, and Analysis, By Distribution Channel (Online Retail, Supermarkets, Others (e.g. Specialty Stores, etc.)), By End Use (Pharmaceutical, Nutraceutical, Others) an...
March 2023
447 pages
Vitamin E Acetate Market Size, Share, and Analysis, By Type (Food Grade Vitamin E Acetate, Pharmaceutical Grade Vitamin E Acetate, Cosmetics Grade Vitamin E Acetate), By Application (Food, Feed, Medical, Cosmetics) And Region – Global Analysis of Market Size, Share & Trends For 2021–2022 and Regional Forecasts, 2022-2032.
US$ 4,950.00
Vitamin E Acetate Market Size, Share, and Analysis, By Type (Food Grade Vitamin E Acetate, Pharmaceutical Grade Vitamin E Acetate, Cosmetics Grade Vitamin E Acetate), By Application (Food, Feed, Medic...
March 2023
491 pages
Best Selling Pharmaceutical Drugs in 2021
US$ 5,500.00
Report : This research report incorporates an in-depth analysis of the pharmaceutical drugs market and its competitive landscape through 2021. Major players, competitive intelligence, innovative techn...
February 2023
255 pages
Pharmaceutical Packaging Market Size, Share & Trends Analysis Report By Material (Plastics & Polymers, Paper & Paperboard, Glass, Aluminum Foil), By Product, By End-use, By Region, And Segment Forecasts, 2023 - 2030
US$ 5,950.00
The global pharmaceutical packaging market size is expected to reach USD 158.24 billion by 2025, according to a new report by ... over the forecast period. The pharmaceutical packaging market is highly fragmented with both domestic and international players sharing the market space. However, it is led by the ...
February 2023
220 pages
Sleep Aids: Technologies and Global Markets
US$ 5,500.00
This BCC Research study analyzes the current therapies for sleep disorders and new therapies that are in the pipeline. It also discusses products, trends, new developments and compensation issues that are currently affecting or are likely to affect the market soon. Forecast provided from 2016 through 2021.
February 2023
152 pages
South & Central America Aquaculture Vaccines Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type of Vaccine (Live Vaccine, Inactivated Vaccine, and Others), Species (Tilapia, Trout, Salmon, Shrimps, and Others), and Route of Administration (Injection Vaccines, Immersion Vaccines, and Oral Vaccines)
US$ 3,000.00
The South & Central America aquaculture vaccines market is expected to grow from US$ 11.47 million in 2022 to US$ 23.07 million by 2028. It is estimated to grow at a CAGR of 12.4% from 2022 to 2028....
February 2023
118 pages
Middle East & Africa Aquaculture Vaccines Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type of Vaccine (Live Vaccine, Inactivated Vaccine, and Others), Species (Tilapia, Trout, Salmon, Shrimps, and Others), and Route of Administration (Injection Vaccines, Immersion Vaccines, and Oral Vaccines)
US$ 3,000.00
The Middle East & Africa aquaculture vaccines market is expected to grow from US$ 6.52 million in 2022 to US$ 12.82 million by 2028. It is estimated to grow at a CAGR of 11.9% from 2022 to 2028. Deve...
February 2023
107 pages
